Skip to content
value.today
GoodRx Holdings, Inc. logo

GoodRx Holdings, Inc.

Total raised
$20 M
2 rounds on record
Latest round
$10 M
Jun 2020
First round on record
Jan 2020
Today
Went public
See the company page

GoodRx Holdings, Inc. is listed today as GoodRx: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of GoodRx Holdings, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2020$10 MNo. 2$10 to $50 million

GoodRx Holdings, Inc.: Raise no. 2, Jun 2020

Investors in this round

1 investor had bought by the notice of Jun 25, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for GoodRx Holdings, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Slutsky · Executive Officer · General Manager and Senior Vice President, Consumer
  • Doug Hirsch · Executive Officer, Director · Co-Chief Executive Officer and Director
  • Karsten Voermann · Executive Officer · Chief Financial Officer
  • Trevor Bezdek · Executive Officer, Director · Co-Chief Executive Officer and Director
  • Adam Karol · Director
  • Agnes Rey-Giraud · Director
  • Christopher Adams · Director
  • Dipanjan Deb · Director
  • Gregory Mondre · Director
  • Jacqueline Kosecoff · Director
  • Stephen LeSieur · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This filing related to grants of options under issuer's 2015 Equity Incentive Plan at prices determined at time of grant. For this purpose, options are valued at their exercise price.”

Signed by Karsten Voermann, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 25, 2020. Read the notice at the SEC.

optionsSEC
Jan 2020$9 MNo. 1$2 to $10 million

GoodRx Holdings, Inc.: Raise no. 1, Jan 2020

Investors in this round

4 investors had bought by the notice of Apr 16, 2020: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for GoodRx Holdings, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrew Slutsky · Executive Officer · General Manager and Senior Vice President, Consumer
  • Doug Hirsch · Executive Officer, Director · Co-Chief Executive Officer and Director
  • Karsten Voermann · Executive Officer · Chief Financial Officer
  • Trevor Bezdek · Executive Officer, Director · Co-Chief Executive Officer and Director
  • Adam Karol · Director
  • Agnes Rey-Giraud · Director
  • Christopher Adams · Director
  • Dipanjan Deb · Director
  • Gregory Mondre · Director
  • Jacqueline Kosecoff · Director
  • Stephen LeSieur · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This filing related to grants of options under issuer's 2015 Equity Incentive Plan at prices determined at time of grant. For this purpose, options are valued at their exercise price.”

Signed by Doug Hirsch, Co-Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 16, 2020. Read the notice at the SEC.

optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company GoodRx, its revenue in fiscal 2025 came from these product and service lines: Prescription transactions revenue $544 million (68%), Pharma manufacturer solutions revenue $151.38 million (19%), Subscription revenue $83.79 million (11%), Other revenue $17.69 million (2%).

    Annual report (SEC XBRL) · Dec 2025

  • GoodRx Holdings, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2020).

    SEC Form D · Jun 2020

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jun 2020

Products#

No products of GoodRx Holdings, Inc. are on record.

Services#

From the company page of GoodRx.

Investors#

5 named in official filings. Open an investor to see everything it has backed.

Investors in GoodRx Holdings, Inc.
InvestorKindAmountRoundRoleSource
Silver Lake Group, L.L.C.Fund or asset managernot statednot statedHeld preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Silver Lake Technology Associates V, L.P.Fund or asset managernot statednot statedHeld preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
SLP Geology Aggregator, L.P.Fund or asset managernot statednot statedHeld preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
SLP Geology GP, L.L.C.Othernot statednot statedHeld preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
Slta V (GP), L.L.C.Othernot statednot statedHeld preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 4 investors.

Largest shareholders today

Institutions holding GoodRx shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by GoodRx Holdings, Inc.
NameRoleNamed in
Andrew SlutskyGeneral Manager and Senior Vice President, ConsumerJun 2020
Doug HirschCo-Chief Executive Officer and DirectorJun 2020
Karsten VoermannChief Financial OfficerJun 2020
Trevor BezdekCo-Chief Executive Officer and DirectorJun 2020
Adam KarolDirectorJun 2020
Agnes Rey-GiraudDirectorJun 2020
Christopher AdamsDirectorJun 2020
Dipanjan DebDirectorJun 2020
Doug HirschCo-Chief Executive Officer and DirectorJun 2020
Gregory MondreDirectorJun 2020
Jacqueline KosecoffDirectorJun 2020
Stephen LeSieurDirectorJun 2020
Trevor BezdekCo-Chief Executive Officer and DirectorJun 2020

Went public since 2020. Its SEC number is that of a company listed on a stock exchange.